BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20839921)

  • 1. Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.
    Lentz MR; Degaonkar M; Mohamed MA; Kim H; Conant K; Halpern EF; Sacktor N; Barker PB; Pomper MG
    J Neurovirol; 2010 Oct; 16(5):368-76. PubMed ID: 20839921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
    Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
    Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
    J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
    Valle M; Price RW; Nilsson A; Heyes M; Verotta D
    Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
    Chang L; Ernst T; St Hillaire C; Conant K
    Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Mohamed MA; Lentz MR; Lee V; Halpern EF; Sacktor N; Selnes O; Barker PB; Pomper MG
    Radiology; 2010 Feb; 254(2):577-86. PubMed ID: 20093528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents.
    Kutza J; Fields K; Grimm TA; Clouse KA
    AIDS Res Hum Retroviruses; 2002 Jun; 18(9):619-25. PubMed ID: 12079557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment.
    Stankoff B; Calvez V; Suarez S; Bossi P; Rosenblum O; Conquy L; Turell E; Dubard T; Coutellier A; Baril L; Bricaire F; Lacomblez L; Lubetzki C
    Eur J Neurol; 1999 Nov; 6(6):669-75. PubMed ID: 10529754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
    Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
    Jobe O; Trinh HV; Kim J; Alsalmi W; Tovanabutra S; Ehrenberg PK; Peachman KK; Gao G; Thomas R; Kim JH; Michael NL; Alving CR; Rao VB; Rao M
    J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
    Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
    J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: amelioration with stavudine.
    Kandanearatchi A; Zuckerman M; Smith M; Vyakarnam A; Everall IP
    AIDS; 2002 Feb; 16(3):413-20. PubMed ID: 11834953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
    Aweeka F; Jayewardene A; Staprans S; Bellibas SE; Kearney B; Lizak P; Novakovic-Agopian T; Price RW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):39-43. PubMed ID: 9928728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.
    Lentz MR; Kim WK; Lee V; Bazner S; Halpern EF; Venna N; Williams K; Rosenberg ES; González RG
    Neurology; 2009 Apr; 72(17):1465-72. PubMed ID: 19398702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage colony-stimulating factor in the pathogenesis of HIV infection: potential target for therapeutic intervention.
    Haine V; Fischer-Smith T; Rappaport J
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):32-40. PubMed ID: 18040789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.